1. Home
  2. STRT vs ALDX Comparison

STRT vs ALDX Comparison

Compare STRT & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STRATTEC SECURITY CORPORATION

STRT

STRATTEC SECURITY CORPORATION

HOLD

Current Price

$90.72

Market Cap

331.1M

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$5.49

Market Cap

317.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRT
ALDX
Founded
1908
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
331.1M
317.7M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
STRT
ALDX
Price
$90.72
$5.49
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.50
AVG Volume (30 Days)
34.5K
672.1K
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
12.53
N/A
EPS
3.26
N/A
Revenue
$439,195,000.00
N/A
Revenue This Year
$4.22
N/A
Revenue Next Year
$2.04
$36.25
P/E Ratio
$27.89
N/A
Revenue Growth
5.24
N/A
52 Week Low
$31.71
$1.18
52 Week High
$92.50
$7.19

Technical Indicators

Market Signals
Indicator
STRT
ALDX
Relative Strength Index (RSI) 59.53 57.78
Support Level $62.09 $4.72
Resistance Level $92.45 $5.75
Average True Range (ATR) 4.48 0.29
MACD -0.08 -0.00
Stochastic Oscillator 85.91 76.22

Price Performance

Historical Comparison
STRT
ALDX

About STRT STRATTEC SECURITY CORPORATION

Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: